Velmurugan Balasubramanian

Velmurugan Balasubramanian

Active Director Director DIN 08136055
DIN 08136055 First appointment May 2018 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since May 2018
Shareholding value •••• Premium profile

About Velmurugan Balasubramanian

Data last updated:

Velmurugan Balasubramanian has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Seragen Biotherapeutics Private Limited and Gensera Biotech Solutions Private Limited. Formerly with 3 companies, such as Revenup Ai Technologies Private Limited and Pollsem Agronomic Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹6.93 Cr; the largest is Seragen Biotherapeutics Private Limited at ₹6.59 Cr (FY 2024).

DIN 08136055
Primary Designation Director
First Appointment 17 May 2018
Oldest Company Age 8 yrs
Largest company Seragen Biotherapeutics Private Limited · ₹6.59 Cr (FY 2024)
Combined revenue ₹6.93 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Jul 20182018₹6.59 Cr (FY 2024)Active
Director31 Aug 20192019₹34.2 Lakh (FY 2023)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 May 20182018–Active
Pollsem Agronomic Private Limited U52100KA2019PTC127674
Director05 Sep 20192019₹11,800 (FY 2024)Active
Director18 Sep 20192019₹84,090 (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Seragen Biotherapeutics Private Limited
Gensera Biotech Solutions Private Limited
Revenup Ai Technologies Private Limited
Pollsem Agronomic Private Limited
Premium access

Shareholding and investment profile for Velmurugan Balasubramanian

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Velmurugan Balasubramanian

Velmurugan Balasubramanian has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Seragen Biotherapeutics Private Limited and Gensera Biotech Solutions Private Limited. Formerly with 3 companies, such as Revenup Ai Technologies Private Limited and Pollsem Agronomic Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹6.93 Cr; the largest is Seragen Biotherapeutics Private Limited at ₹6.59 Cr (FY 2024).

Velmurugan Balasubramanian is associated with 2 companies as Director, including Seragen Biotherapeutics Private Limited (₹6.59 Cr), Gensera Biotech Solutions Private Limited (₹34.2 Lakh).

Velmurugan Balasubramanian has expertise in General Business, Technology.

Velmurugan Balasubramanian has 8 years in corporate governance.

By reported revenue, the largest current company of Velmurugan Balasubramanian is Seragen Biotherapeutics Private Limited, with revenue of ₹6.59 Cr (FY 2024).

The 2 current companies of Velmurugan Balasubramanian that report revenue have a combined latest revenue of ₹6.93 Cr.

Velmurugan Balasubramanian currently holds positions at 2 companies: Seragen Biotherapeutics Private Limited (₹6.59 Cr), Gensera Biotech Solutions Private Limited (₹34.2 Lakh).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available